James Talks
| Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration | 2025 |
|
James Talks
| Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic Staff | 2025 |
|
Dr Jeffry Hogg
Professor Katie Brittain
James Talks
Rosemary Nicholls
Dr Gregory Maniatopoulos
et al. | Intervention design for artificial intelligence-enabled macular service implementation: a primary qualitative study | 2024 |
|
Professor David Steel
James Talks
| Diabetic Macular Edema and Diode Subthreshold Micropulse Laser: A Randomized Double-Masked Noninferiority Clinical Trial | 2023 |
|
James Talks
| Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration | 2021 |
|
James Talks
| Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic Review | 2021 |
|
Dr Jeffry Hogg
James Talks
Professor Mark Pearce
| Real-World Visual and Neovascularisation Outcomes from anti-VEGF in Central Retinal Vein Occlusion | 2021 |
|
Dr Jeffry Hogg
James Talks
| Comment on: Clinical outcomes in Caucasian patients with polypoidal choroidal vasculopathy | 2019 |
|
James Talks
| Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - A systematic approach to identify and characterize data sources | 2019 |
|
James Talks
| The use of real-world evidence for evaluating anti–vascular endothelial growth factor treatment of neovascular age-related macular degeneration | 2019 |
|
James Talks
| United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: Report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services | 2019 |
|
James Talks
| Defining response to anti-VEGF therapies in neovascular AMD | 2015 |
|
James Talks
| Metabolomic analysis of urine in patients with age related macular degeneration | 2015 |
|
James Talks
Vina Manjunath Manjunath
Professor David Steel
Professor Roy Taylor
| New vessels detected on wide-field imaging compared to two-field and seven-field imaging: implications for diabetic retinopathy screening image analysis | 2015 |
|
James Talks
| Treat-And-Extend Regimens with Anti-Vegf Agents in Retinal Diseases | 2015 |
|
Vina Manjunath
James Talks
| UK outcomes of switching patients with neovascular age-related macular degeneration from ranibizumab to Aflibercept | 2015 |
|
James Talks
| Bevacizumab for retinal disorders: Macular degeneration needs longer lasting treatments | 2014 |
|
James Talks
Andrew Browning
| Alternative diagnosis for cases presented as vPED treated with high-dose ranibizumab | 2012 |
|
James Talks
| Akute makuläre Neuroretinopathie [Acute macular neuroretinopathy] | 2011 |
|
Dr Robert James
Professor Simon Pearce
James Talks
| A second corneal arcus? | 2007 |
|
James Talks
| Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone | 2007 |
|
Dr Sara Brown
James Talks
Dr Stephanie Needham
Dr Aileen Taylor
| Pseudoxanthoma elasticum: biopsy of clinically normal skin in the investigation of patients with angioid streaks | 2007 |
|
Michael Birch
James Talks
| Short-term effects of focal argon laser treatment in diabetic maculopathy as demonstrated by optical coherence tomography | 2007 |
|
James Talks
| Correlation of optical coherence tomography and fundus fluorescein angiography following photodynamic therapy for choroidal neovascular membranes | 2006 |
|
Dr Sara Brown
James Talks
Dr Stephanie Needham
Dr Aileen Taylor
| Does biopsy of clinically normal skin facilitate the diagnosis of pseudoxanthoma etasticum? | 2006 |
|
James Talks
| Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes | 2005 |
|
Dr Keith Mitchell
James Talks
| Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin | 2005 |
|
James Talks
| Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks - One-year results of a prospective case series | 2005 |
|
James Talks
| The incidence and outcome of photodynamic therapy for macular degeneration in the Northern Region of the UK | 2004 |
|
James Talks
| The value of stratus optical coherence tomography in retreatment of choroidal neovascular membranes with photodynamic therapy. | 2004 |
|
